Birdwatch Archive

Birdwatch Note

2024-10-30 19:36:10 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Imane Khelif est une femme souffrant d’une maladie augmentant son taux de testostérone. Sources : https://www.madmoizelle.com/la-boxeuse-algerienne-imane-khelif-au-coeur-dune-polemique-sur-son-hyperandrogenie-1768751 https://fr.news.yahoo.com/jo-paris-2024-quest-ce-que-lhyperandrogenie-dont-la-boxeuse-imane-khelif-est-atteinte-113641462.html

Written by CA64BAB18A4D4511A010AE7CF3E486A08700DDE19D733C5FD13F07072A943023
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1851540266110377995

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1851709701815439782
  • noteId - 1851709701815439782
  • participantId -
  • noteAuthorParticipantId - CA64BAB18A4D4511A010AE7CF3E486A08700DDE19D733C5FD13F07072A943023 Participant Details
  • createdAtMillis - 1730316970673
  • tweetId - 1851540266110377995
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Imane Khelif est une femme souffrant d’une maladie augmentant son taux de testostérone. Sources : https://www.madmoizelle.com/la-boxeuse-algerienne-imane-khelif-au-coeur-dune-polemique-sur-son-hyperandrogenie-1768751 https://fr.news.yahoo.com/jo-paris-2024-quest-ce-que-lhyperandrogenie-dont-la-boxeuse-imane-khelif-est-atteinte-113641462.html

Note Ratings

rated at rated by
2024-10-31 09:46:48 -0500 Rating Details
2024-10-31 02:49:42 -0500 Rating Details
2024-10-31 00:33:46 -0500 Rating Details
2024-10-30 20:08:24 -0500 Rating Details
2024-10-30 19:49:57 -0500 Rating Details
2024-10-30 18:42:42 -0500 Rating Details
2024-10-30 18:34:17 -0500 Rating Details
2024-10-30 16:52:36 -0500 Rating Details
2024-10-30 14:47:31 -0500 Rating Details
2024-11-01 02:25:05 -0500 Rating Details
2024-10-31 15:09:58 -0500 Rating Details
2024-10-31 12:30:38 -0500 Rating Details
2024-10-31 05:34:51 -0500 Rating Details
2024-10-31 04:32:41 -0500 Rating Details
2024-10-31 02:04:31 -0500 Rating Details
2024-10-30 17:46:56 -0500 Rating Details
2024-10-30 16:44:26 -0500 Rating Details
2024-10-30 15:47:59 -0500 Rating Details
2024-10-30 15:18:19 -0500 Rating Details
2024-11-04 04:52:44 -0600 Rating Details
2024-11-01 00:02:40 -0500 Rating Details
2024-10-31 07:04:28 -0500 Rating Details
2024-10-31 04:54:38 -0500 Rating Details
2024-10-31 01:37:53 -0500 Rating Details
2024-10-30 19:33:23 -0500 Rating Details
2024-10-30 18:56:51 -0500 Rating Details
2024-10-30 18:44:38 -0500 Rating Details
2024-10-30 15:31:29 -0500 Rating Details
2024-10-30 15:24:32 -0500 Rating Details
2024-10-31 09:28:59 -0500 Rating Details
2024-10-31 05:01:26 -0500 Rating Details
2024-10-31 02:01:01 -0500 Rating Details
2024-10-30 18:16:39 -0500 Rating Details
2024-10-30 17:11:45 -0500 Rating Details
2024-10-30 17:06:18 -0500 Rating Details
2024-10-30 16:36:45 -0500 Rating Details
2024-10-30 14:55:23 -0500 Rating Details
2024-10-31 16:55:10 -0500 Rating Details
2024-10-31 13:41:20 -0500 Rating Details
2024-10-31 03:58:30 -0500 Rating Details
2024-10-31 00:18:26 -0500 Rating Details
2024-10-30 19:08:49 -0500 Rating Details
2024-10-30 19:05:42 -0500 Rating Details
2024-10-30 16:15:12 -0500 Rating Details
2024-10-30 15:56:59 -0500 Rating Details
2024-10-30 15:43:27 -0500 Rating Details
2024-10-30 15:32:31 -0500 Rating Details
2024-10-30 14:57:40 -0500 Rating Details